Brightgene Bio-medical Technology Co. Ltd. Class ASSE: 688166

2025 Annual Report

Mar 20, 2026 · Issued by Brightgene Bio-medical Technology Co. Ltd. Class A via Shanghai Stock Exchange

2025 Annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment